Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT03561532
Eligibility Criteria:
Inclusion Criteria:
* • • Diagnosis of CU based on clinical, endoscopic, and histological findings.
* Remission assessed by Mayo score (0 to 1) and F-Calpro (\<100 ug/g).
* Availability of consecutive fecal samples during one year after the diagnosis of CU.
* Availability of blood sample to study the IBD associated genetic background
* Compliance to attend ileocolonoscopy and FMT within 3-6 months after the diagnosis of CU and at 52 week
* 18-75 years
Exclusion Criteria:
* Unable to provide informed consent
* Need for any antibiotic therapy within 3 months
* Use of corticosteroids, immunosuppressive or biological medication at the baseline
* Use of any probiotics
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT03561532
Study Brief:
Protocol Section:
NCT03561532